{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:13:48Z","timestamp":1792707228121,"version":"4.5.0"},"reference-count":184,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001202","name":"Gastroenterological Society of Australia","doi-asserted-by":"publisher","award":["-"],"award-info":[{"award-number":["-"]}],"id":[{"id":"10.13039\/501100001202","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2026,4]]},"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n Transjugular intrahepatic portosystemic shunt (TIPS) is one of the preferred interventional radiology techniques for reducing clinically significant portal pressures in patients with cirrhosis and complications from portal hypertension when pharmacological therapy or endoscopic interventions have failed or been insufficient. Recent advances in TIPS procedural techniques and stent technology, along with emerging indications for TIPS, warrant a review of current practices and establishment of consensus recommendations in Australia, where TIPS remains underused. This TIPS consensus statement is the first such guideline in Australia. It outlines 69 evidence-based practice recommendations and the evidence underlying them. The recommendations are intended for use by health care professionals in Australia who manage adult patients with portal hypertensive complications of liver disease, where such patients are being considered for TIPS implantation, including pre-, peri- and post-procedural aspects of care.<\/jats:p>\n <\/jats:sec>\n \n Methods and results<\/jats:title>\n This consensus statement has been developed by specialists in hepatology and interventional radiology, with input from specialists in cardiology, hematology and primary care, including medical practitioners, nurses and clinical researchers. The statement deals with four domains related to TIPS: preparation for TIPS, patient selection and pre-TIPS workup; best procedural practice; postoperative care and follow-up; and indications for TIPS. Two rounds of a modified Delphi process were used to reach consensus on the recommendations.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n \n Adoption of and adherence to the evidence-based recommendations in this consensus statement should reduce clinical variation. Ultimately, this should lead to system-level improvements in quality of care and outcomes for patients undergoing TIPS implantation. These recommendations summarize the complete document, available at\n https:\/\/www.gesa.org.au\/resources\/<\/jats:ext-link>\n .\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1007\/s12072-025-11023-x","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T15:20:17Z","timestamp":1772551217000},"page":"215-239","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Australian best practice recommendations for transjugular intrahepatic portosystemic shunt (TIPS) in portal hypertension: a consensus statement"],"prefix":"10.1007","volume":"20","author":[{"given":"Eric","family":"Kalo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacinta","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Purnima","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winita","family":"Hardikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishita","family":"Jagarlamudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai See","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cositha","family":"Santhakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Read","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Braund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei Wen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anouk","family":"Dev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Grieve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Koukounaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivendra","family":"Lalloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vi","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Mott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Raj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Ranatunga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Tallis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zina","family":"Valaydon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diederick","family":"De Boo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enoka","family":"Gonsalkorala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashid","family":"Muddassir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thao","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Tibballs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penny","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rozemary","family":"Karamatic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerry","family":"Macquillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Rogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Shackel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Olynyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Leggett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharth","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Strasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radha","family":"Popuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Lubel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"O\u2019Beirne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avik","family":"Majumdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0026-1457","authenticated-orcid":false,"given":"Golo","family":"Ahlenstiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Gastroenterological Society of Australia (GESA)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"issue":"1","key":"11023_CR1","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1097\/HEP.0000000000000530","volume":"79","author":"EW Lee","year":"2024","unstructured":"Lee EW, Eghtesad B, Garcia-Tsao G, Haskal ZJ, Hernandez-Gea V, Jalaeian H, et al. AASLD Practice Guidance on the use of TIPS, variceal embolization, and retrograde transvenous obliteration in the management of variceal hemorrhage. Hepatology 2024;79(1):224\u2013250","journal-title":"Hepatology"},{"issue":"1","key":"11023_CR2","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/hep.23383","volume":"51","author":"TD Boyer","year":"2010","unstructured":"Boyer TD, Haskal ZJ, American Association for the Study of Liver D. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension: update 2009. Hepatology 2010;51(1):306","journal-title":"Hepatology"},{"issue":"2","key":"11023_CR3","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","volume":"69","author":"European Association for the Study of the L","year":"2018","unstructured":"European Association for the Study of the L. EASL clinical practice guidelines for the management of patients with decompensated cirrhosis. J Hepatol 2018;69(2):406\u2013460","journal-title":"J Hepatol"},{"issue":"7","key":"11023_CR4","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1136\/gutjnl-2019-320221","volume":"69","author":"D Tripathi","year":"2020","unstructured":"Tripathi D, Stanley AJ, Hayes PC, Travis S, Armstrong MJ, Tsochatzis EA, et al. Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension. Gut 2020;69(7):1173\u20131192","journal-title":"Gut"},{"key":"11023_CR5","doi-asserted-by":"crossref","unstructured":"Boike JR, Thornburg BG, Asrani SK, Fallon MB, Fortune BE, Izzy MJ, et al. North American practice-based recommendations for transjugular intrahepatic portosystemic shunts in portal hypertension. Clin Gastroenterol Hepatol 2022;20(8):1636\u201362 e36","DOI":"10.1016\/j.cgh.2021.07.018"},{"issue":"4","key":"11023_CR6","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","volume":"76","author":"R de Franchis","year":"2022","unstructured":"de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C, Baveno VIIF. Baveno VII\u2014renewing consensus in portal hypertension. J Hepatol 2022;76(4):959\u2013974","journal-title":"J Hepatol"},{"issue":"2","key":"11023_CR7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.dld.2016.10.011","volume":"49","author":"S Fagiuoli","year":"2017","unstructured":"Fagiuoli S, Bruno R, Debernardi Venon W, Schepis F, Vizzutti F, Toniutto P, et al. Consensus conference on TIPS management: techniques, indications, contraindications. Dig Liver Dis 2017;49(2):121\u2013137","journal-title":"Dig Liver Dis"},{"issue":"Suppl 3","key":"11023_CR8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00508-017-1262-3","volume":"129","author":"T Reiberger","year":"2017","unstructured":"Reiberger T, Puspok A, Schoder M, Baumann-Durchschein F, Bucsics T, Datz C, et al. Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III). Wien Klin Wochenschr 2017;129(Suppl 3):135\u2013158","journal-title":"Wien Klin Wochenschr"},{"issue":"Suppl 3","key":"11023_CR9","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00508-023-02229-w","volume":"135","author":"M Mandorfer","year":"2023","unstructured":"Mandorfer M, Aigner E, Cejna M, Ferlitsch A, Datz C, Grater T, et al. Austrian consensus on the diagnosis and management of portal hypertension in advanced chronic liver disease (Billroth IV). Wien Klin Wochenschr 2023;135(Suppl 3):493\u2013523","journal-title":"Wien Klin Wochenschr"},{"issue":"9","key":"11023_CR10","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1111\/liv.15976","volume":"44","author":"H Larrue","year":"2024","unstructured":"Larrue H, Allaire M, Weil-Verhoeven D, Barge S, Thabut D, Payance A, et al. French guidelines on TIPS: indications and modalities. Liver Int 2024;44(9):2125\u20132143","journal-title":"Liver Int"},{"issue":"12","key":"11023_CR11","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1007\/s00270-024-03866-y","volume":"47","author":"P Lucatelli","year":"2024","unstructured":"Lucatelli P, Krajina A, Loffroy R, Miraglia R, Pieper CC, Franchi-Abella S, et al. CIRSE standards of practice on transjugular intrahepatic portosystemic shunts. Cardiovasc Intervent Radiol 2024;47(12):1710\u20131726","journal-title":"Cardiovasc Intervent Radiol"},{"key":"11023_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2023-001308","author":"E Kalo","year":"2024","unstructured":"Kalo E, Read S, George J, Roberts SK, Majumdar A, Ahlenstiel G. Attitudes towards transjugular intrahepatic portosystemic shunt (TIPS) in Australia: a national survey of TIPS centres. BMJ Open Gastroenterol 2024. https:\/\/doi.org\/10.1136\/bmjgast-2023-001308","journal-title":"BMJ Open Gastroenterol"},{"issue":"18","key":"11023_CR13","doi-asserted-by":"publisher","first-page":"E839","DOI":"10.1503\/cmaj.090449","volume":"182","author":"MC Brouwers","year":"2010","unstructured":"Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ 2010;182(18):E839\u2013E842","journal-title":"CMAJ"},{"key":"11023_CR14","unstructured":"Council NHaMR. Guidelines for Guidelines: Assessing Certainty of Evidence. Canberra: NHMRC"},{"issue":"7650","key":"11023_CR15","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336(7650):924\u2013926","journal-title":"BMJ"},{"issue":"1","key":"11023_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jvir.2015.09.018","volume":"27","author":"SR Dariushnia","year":"2016","unstructured":"Dariushnia SR, Haskal ZJ, Midia M, Martin LG, Walker TG, Kalva SP, et al. Quality improvement guidelines for transjugular intrahepatic portosystemic shunts. J Vasc Interv Radiol 2016;27(1):1\u20137","journal-title":"J Vasc Interv Radiol"},{"issue":"6","key":"11023_CR17","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1002\/hep4.1345","volume":"3","author":"JM Mah","year":"2019","unstructured":"Mah JM, DeWit Y, Djerboua M, Menard A, Booth CM, Flemming JA. Association between institutional factors and long\u2010term survival following transjugular intrahepatic portosystemic shunt. Hepatol Commun 2019;3(6):838\u2013846","journal-title":"Hepatol Commun"},{"issue":"2","key":"11023_CR18","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1002\/hep.29354","volume":"67","author":"A Sarwar","year":"2018","unstructured":"Sarwar A, Zhou L, Novack V, Tapper EB, Curry M, Malik R, et al. Hospital volume and mortality after transjugular intrahepatic portosystemic shunt creation in the United States. Hepatology 2018;67(2):690\u2013699","journal-title":"Hepatology"},{"issue":"8","key":"11023_CR19","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1111\/liv.15236","volume":"42","author":"L Furschuss","year":"2022","unstructured":"Furschuss L, Rainer F, Effenberger M, Niederreiter M, Portugaller RH, Horvath A, et al. A novel score predicts mortality after transjugular intrahepatic portosystemic shunt: MOTS-Modified TIPS Score. Liver Int 2022;42(8):1849\u20131860","journal-title":"Liver Int"},{"key":"11023_CR20","doi-asserted-by":"crossref","unstructured":"Gaba RC, Couture PM, Bui JT, Knuttinen MG, Walzer NM, Kallwitz ER, et al. Prognostic capability of different liver disease scoring systems for prediction of early mortality after transjugular intrahepatic portosystemic shunt creation. J Vasc Interv Radiol 2013;24(3):411\u2013420.e1\u20134","DOI":"10.1016\/j.jvir.2012.10.026"},{"issue":"10","key":"11023_CR21","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1056\/NEJMoa0801209","volume":"359","author":"WR Kim","year":"2008","unstructured":"Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 2008;359(10):1018\u20131026","journal-title":"N Engl J Med"},{"issue":"1","key":"11023_CR22","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1053\/gast.2003.50016","volume":"124","author":"R Wiesner","year":"2003","unstructured":"Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003;124(1):91\u201396","journal-title":"Gastroenterology"},{"issue":"8","key":"11023_CR23","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/bjs.1800600817","volume":"60","author":"RN Pugh","year":"1973","unstructured":"Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. J Br Surg 1973;60(8):646\u2013649","journal-title":"J Br Surg"},{"issue":"5","key":"11023_CR24","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1111\/j.1572-0241.2003.07515.x","volume":"98","author":"M Schepke","year":"2003","unstructured":"Schepke M, Roth F, Fimmers R, Brensing KA, Sudhop T, Schild HH, et al. Comparison of Meld, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting. Am J Gastroenterol 2003;98(5):1167\u20131174","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"11023_CR25","doi-asserted-by":"publisher","first-page":"255","DOI":"10.2214\/AJR.21.27301","volume":"219","author":"C Yang","year":"2022","unstructured":"Yang C, Chen Q, Zhou C, Liu J, Huang S, Wang Y, et al. FIPS score for prediction of survival after TIPS placement: external validation and comparison with traditional risk scores in a cohort of Chinese patients with cirrhosis. AJR Am J Roentgenol 2022;219(2):255\u2013267","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"11023_CR26","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/hep.32704","volume":"77","author":"F Vizzutti","year":"2023","unstructured":"Vizzutti F, Celsa C, Calvaruso V, Enea M, Battaglia S, Turco L, et al. Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: a validated prediction model. Hepatology 2023;77(2):476\u2013488","journal-title":"Hepatology"},{"issue":"7","key":"11023_CR27","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1111\/j.1478-3231.2010.02272.x","volume":"30","author":"F Salerno","year":"2010","unstructured":"Salerno F, Guevara M, Bernardi M, Moreau R, Wong F, Angeli P, et al. Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis. Liver Int 2010;30(7):937\u2013947","journal-title":"Liver Int"},{"issue":"6","key":"11023_CR28","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.jhep.2021.01.023","volume":"74","author":"D Bettinger","year":"2021","unstructured":"Bettinger D, Sturm L, Pfaff L, Hahn F, Kloeckner R, Volkwein L, et al. Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival. J Hepatol 2021;74(6):1362\u20131372","journal-title":"J Hepatol"},{"issue":"9","key":"11023_CR29","doi-asserted-by":"publisher","first-page":"4581","DOI":"10.1007\/s10620-021-07307-5","volume":"67","author":"SE Chapin","year":"2022","unstructured":"Chapin SE, Goldberg DS, Kaplan DE, Mahmud N. External validation of the FIPS score for post-TIPS mortality in a national Veterans Affairs cohort. Dig Dis Sci 2022;67(9):4581\u20134589","journal-title":"Dig Dis Sci"},{"issue":"3","key":"11023_CR30","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.jhep.2021.05.042","volume":"75","author":"Q Wang","year":"2021","unstructured":"Wang Q, Bai W, Han G. Freiburg index of post-TIPS survival: the first score for individual prediction and a complementary tool for risk stratification. J Hepatol 2021;75(3):747\u2013749","journal-title":"J Hepatol"},{"issue":"8","key":"11023_CR31","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1016\/j.cgh.2021.07.018","volume":"20","author":"JR Boike","year":"2022","unstructured":"Boike JR, Thornburg BG, Asrani SK, Fallon MB, Fortune BE, Izzy MJ, et al. North American practice-based recommendations for transjugular intrahepatic portosystemic shunts in portal hypertension. Clin Gastroenterol Hepatol 2022;20(8):1636\u20131662.e36","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"11023_CR32","doi-asserted-by":"publisher","first-page":"675","DOI":"10.2214\/AJR.10.4819","volume":"196","author":"RC Gaba","year":"2011","unstructured":"Gaba RC, Khiatani VL, Knuttinen MG, Omene BO, Carrillo TC, Bui JT, et al. Comprehensive review of TIPS technical complications and how to avoid them. AJR Am J Roentgenol 2011;196(3):675\u2013685","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"11023_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/heart.87.1.9","volume":"87","author":"S Moller","year":"2002","unstructured":"Moller S, Henriksen JH. Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease. Heart 2002;87(1):9\u201315","journal-title":"Heart"},{"issue":"3","key":"11023_CR34","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nrgastro.2013.210","volume":"11","author":"S Wiese","year":"2014","unstructured":"Wiese S, Hove JD, Bendtsen F, Moller S. Cirrhotic cardiomyopathy: pathogenesis and clinical relevance. Nat Rev Gastroenterol Hepatol 2014;11(3):177\u2013186","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"11023_CR35","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s12072-008-9109-7","volume":"3","author":"F Wong","year":"2009","unstructured":"Wong F. Cirrhotic cardiomyopathy. Hepatol Int 2009;3(1):294\u2013304","journal-title":"Hepatol Int"},{"issue":"4","key":"11023_CR36","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.jhep.2018.01.006","volume":"69","author":"S Moller","year":"2018","unstructured":"Moller S, Lee SS. Cirrhotic cardiomyopathy. J Hepatol 2018;69(4):958\u2013960","journal-title":"J Hepatol"},{"issue":"10","key":"11023_CR37","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1007\/BF02208995","volume":"40","author":"JM Rodriguez-Laiz","year":"1995","unstructured":"Rodriguez-Laiz JM, Banares R, Echenagusia A, Casado M, Camunez F, Perez-Roldan F, et al. Effects of transjugular intrahepatic portasystemic shunt (TIPS) on splanchnic and systemic hemodynamics, and hepatic function in patients with portal hypertension. Preliminary results. Dig Dis Sci 1995;40(10):2121\u20132127","journal-title":"Dig Dis Sci"},{"issue":"6","key":"11023_CR38","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1002\/hep.30934","volume":"70","author":"C Billey","year":"2019","unstructured":"Billey C, Billet S, Robic MA, Cognet T, Guillaume M, Vinel JP, et al. A prospective study identifying predictive factors of cardiac decompensation after transjugular intrahepatic portosystemic shunt: the Toulouse algorithm. Hepatology 2019;70(6):1928\u20131941","journal-title":"Hepatology"},{"issue":"4","key":"11023_CR39","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","volume":"76","author":"R de Franchis","year":"2022","unstructured":"de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C, Baveno VIIF. Baveno VII-renewing consensus in portal hypertension. J Hepatol 2022;76(4):959\u2013974","journal-title":"J Hepatol"},{"issue":"7","key":"11023_CR40","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1097\/TP.0000000000001229","volume":"100","author":"MJ Krowka","year":"2016","unstructured":"Krowka MJ, Fallon MB, Kawut SM, Fuhrmann V, Heimbach JK, Ramsay MA, et al. International Liver Transplant Society practice guidelines: diagnosis and management of hepatopulmonary syndrome and portopulmonary hypertension. Transplantation 2016;100(7):1440\u20131452","journal-title":"Transplantation"},{"issue":"4","key":"11023_CR41","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1002\/hep.31415","volume":"72","author":"HM DuBrock","year":"2020","unstructured":"DuBrock HM, Krowka MJ. The myths and realities of portopulmonary hypertension. Hepatology 2020;72(4):1455\u20131460","journal-title":"Hepatology"},{"issue":"3","key":"11023_CR42","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/ehjci\/jev014","volume":"16","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2015;16(3):233\u2013270","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"3","key":"11023_CR43","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/hep4.1308","volume":"3","author":"C Jansen","year":"2019","unstructured":"Jansen C, Schroder A, Schueler R, Lehmann J, Praktiknjo M, Uschner FE, et al. Left ventricular longitudinal contractility predicts acute-on-chronic liver failure development and mortality after transjugular intrahepatic portosystemic shunt. Hepatol Commun 2019;3(3):340\u2013347","journal-title":"Hepatol Commun"},{"key":"11023_CR44","unstructured":"European Association for the Study of the Liver. Electronic address eee, European Association for the Study of the L. EASL Clinical Practice Guidelines on nutrition in chronic liver disease. J Hepatol 2019;70(1):172\u2013193"},{"issue":"6","key":"11023_CR45","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.cgh.2016.10.028","volume":"15","author":"S Nardelli","year":"2017","unstructured":"Nardelli S, Lattanzi B, Torrisi S, Greco F, Farcomeni A, Gioia S, et al. Sarcopenia is risk factor for development of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt placement. Clin Gastroenterol Hepatol 2017;15(6):934\u2013936","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"11023_CR46","doi-asserted-by":"publisher","first-page":"406","DOI":"10.5152\/tjg.2023.21964","volume":"34","author":"P Bhatia Kapoor","year":"2023","unstructured":"Bhatia Kapoor P, Benjamin J, Tripathi H, Patidar Y, Maiwall R, Kumar G, et al. Post-transjugular intrahepatic portosystemic shunt hepatic encephalopathy: sarcopenia adds insult to injury. Turk J Gastroenterol 2023;34(4):406\u2013412","journal-title":"Turk J Gastroenterol"},{"issue":"5","key":"11023_CR47","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1007\/s00270-020-02754-5","volume":"44","author":"I Cam","year":"2021","unstructured":"Cam I, Gencturk M, Lim N, Sharma S, Wong J, Yang M, et al. Alcohol recidivism following transjugular intrahepatic portosystemic shunt placement: frequency and predictive factors. Cardiovasc Intervent Radiol 2021;44(5):758\u2013765","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"9","key":"11023_CR48","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.jvir.2010.05.009","volume":"21","author":"CL Anderson","year":"2010","unstructured":"Anderson CL, Saad WE, Kalagher SD, Caldwell S, Sabri S, Turba UC, et al. Effect of transjugular intrahepatic portosystemic shunt placement on renal function: a 7-year, single-center experience. J Vasc Interv Radiol 2010;21(9):1370\u20131376","journal-title":"J Vasc Interv Radiol"},{"issue":"2","key":"11023_CR49","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/hep.510280219","volume":"28","author":"M Guevara","year":"1998","unstructured":"Guevara M, Gines P, Bandi JC, Gilabert R, Sort P, Jimenez W, et al. Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems. Hepatology 1998;28(2):416\u2013422","journal-title":"Hepatology"},{"issue":"9053","key":"11023_CR50","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S0140-6736(97)24010-9","volume":"349","author":"KA Brensing","year":"1997","unstructured":"Brensing KA, Textor J, Strunk H, Klehr HU, Schild H, Sauerbruch T. Transjugular intrahepatic portosystemic stent-shunt for hepatorenal syndrome. Lancet 1997;349(9053):697\u2013698","journal-title":"Lancet"},{"issue":"3","key":"11023_CR51","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1053\/j.ajkd.2016.02.041","volume":"68","author":"AS Allegretti","year":"2016","unstructured":"Allegretti AS, Ortiz G, Cui J, Wenger J, Bhan I, Chung RT, et al. Changes in kidney function after transjugular intrahepatic portosystemic shunts versus large-volume paracentesis in cirrhosis: a matched cohort analysis. Am J Kidney Dis 2016;68(3):381\u2013391","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"11023_CR52","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1023\/A:1018861827399","volume":"42","author":"JP Martinet","year":"1997","unstructured":"Martinet JP, Fenyves D, Legault L, Roy L, Dufresne MP, Spahr L, et al. Treatment of refractory ascites using transjugular intrahepatic portosystemic shunt (TIPS): a caution. Dig Dis Sci 1997;42(1):161\u2013166","journal-title":"Dig Dis Sci"},{"issue":"54","key":"11023_CR53","first-page":"1753","volume":"50","author":"G Testino","year":"2003","unstructured":"Testino G, Ferro C, Sumberaz A, Messa P, Morelli N, Guadagni B, et al. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation. Hepatogastroenterology 2003;50(54):1753\u20131755","journal-title":"Hepatogastroenterology"},{"issue":"1","key":"11023_CR54","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/ki.1979.8","volume":"15","author":"ET Schroeder","year":"1979","unstructured":"Schroeder ET, Anderson GH Jr., Smulyan H. Effects of a portacaval or peritoneovenous shunt on renin in the hepatorenal syndrome. Kidney Int 1979;15(1):54\u201361","journal-title":"Kidney Int"},{"issue":"2","key":"11023_CR55","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1136\/gut.47.2.288","volume":"47","author":"KA Brensing","year":"2000","unstructured":"Brensing KA, Textor J, Perz J, Schiedermaier P, Raab P, Strunk H, et al. Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study. Gut 2000;47(2):288\u2013295","journal-title":"Gut"},{"issue":"6","key":"11023_CR56","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s40620-015-0187-z","volume":"28","author":"J Danziger","year":"2015","unstructured":"Danziger J, Thummalakunta L, Nelson R, Faintuch S. The risk of acute kidney injury with transjugular intrahepatic portosystemic shunts. J Nephrol 2015;28(6):725\u2013728","journal-title":"J Nephrol"},{"issue":"23","key":"11023_CR57","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1056\/NEJM200006083422303","volume":"342","author":"M Rossle","year":"2000","unstructured":"Rossle M, Ochs A, Gulberg V, Siegerstetter V, Holl J, Deibert P, et al. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med 2000;342(23):1701\u20131707","journal-title":"N Engl J Med"},{"issue":"6","key":"11023_CR58","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1053\/gast.2002.37073","volume":"123","author":"P Gines","year":"2002","unstructured":"Gines P, Uriz J, Calahorra B, Garcia-Tsao G, Kamath PS, Del Arbol LR, et al. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology 2002;123(6):1839\u20131847","journal-title":"Gastroenterology"},{"issue":"3","key":"11023_CR59","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1053\/gast.2003.50088","volume":"124","author":"AJ Sanyal","year":"2003","unstructured":"Sanyal AJ, Genning C, Reddy KR, Wong F, Kowdley KV, Benner K, et al. The North American study for the treatment of refractory ascites. Gastroenterology 2003;124(3):634\u2013641","journal-title":"Gastroenterology"},{"issue":"3","key":"11023_CR60","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/hep.20364","volume":"40","author":"F Salerno","year":"2004","unstructured":"Salerno F, Merli M, Riggio O, Cazzaniga M, Valeriano V, Pozzi M, et al. Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites. Hepatology 2004;40(3):629\u2013635","journal-title":"Hepatology"},{"issue":"4","key":"11023_CR61","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1002\/hep.20386","volume":"40","author":"A Monescillo","year":"2004","unstructured":"Monescillo A, Martinez-Lagares F, Ruiz-del-Arbol L, Sierra A, Guevara C, Jimenez E, et al. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology 2004;40(4):793\u2013801","journal-title":"Hepatology"},{"issue":"7","key":"11023_CR62","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1136\/gutjnl-2018-317057","volume":"68","author":"Y Lv","year":"2019","unstructured":"Lv Y, Zuo L, Zhu X, Zhao J, Xue H, Jiang Z, et al. Identifying optimal candidates for early TIPS among patients with cirrhosis and acute variceal bleeding: a multicentre observational study. Gut 2019;68(7):1297\u20131310","journal-title":"Gut"},{"issue":"2","key":"11023_CR63","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0168-8278(96)80065-1","volume":"25","author":"D Lebrec","year":"1996","unstructured":"Lebrec D, Giuily N, Hadengue A, Vilgrain V, Moreau R, Poynard T, et al. Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. French Group of Clinicians and a Group of Biologists. J Hepatol 1996;25(2):135\u2013144","journal-title":"J Hepatol"},{"issue":"1","key":"11023_CR64","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1053\/j.gastro.2016.09.016","volume":"152","author":"C Bureau","year":"2017","unstructured":"Bureau C, Thabut D, Oberti F, Dharancy S, Carbonell N, Bouvier A, et al. Transjugular intrahepatic portosystemic shunts with covered stents increase transplant-free survival of patients with cirrhosis and recurrent ascites. Gastroenterology 2017;152(1):157\u2013163","journal-title":"Gastroenterology"},{"issue":"1","key":"11023_CR65","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s00535-010-0282-9","volume":"46","author":"Y Narahara","year":"2011","unstructured":"Narahara Y, Kanazawa H, Fukuda T, Matsushita Y, Harimoto H, Kidokoro H, et al. Transjugular intrahepatic portosystemic shunt versus paracentesis plus albumin in patients with refractory ascites who have good hepatic and renal function: a prospective randomized trial. J Gastroenterol 2011;46(1):78\u201385","journal-title":"J Gastroenterol"},{"issue":"2","key":"11023_CR66","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1053\/jhep.2002.30418","volume":"35","author":"A Escorsell","year":"2002","unstructured":"Escorsell A, Banares R, Garcia-Pagan JC, Gilabert R, Moitinho E, Piqueras B, et al. TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial. Hepatology 2002;35(2):385\u2013392","journal-title":"Hepatology"},{"issue":"1","key":"11023_CR67","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/hep.510290125","volume":"29","author":"L Garcia-Villarreal","year":"1999","unstructured":"Garcia-Villarreal L, Martinez-Lagares F, Sierra A, Guevara C, Marrero JM, Jimenez E, et al. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal rebleeding after recent variceal hemorrhage. Hepatology 1999;29(1):27\u201332","journal-title":"Hepatology"},{"issue":"6","key":"11023_CR68","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1053\/j.gastro.2006.02.008","volume":"130","author":"JM Henderson","year":"2006","unstructured":"Henderson JM, Boyer TD, Kutner MH, Galloway JR, Rikkers LF, Jeffers LJ, et al. Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trial. Gastroenterology 2006;130(6):1643\u20131651","journal-title":"Gastroenterology"},{"issue":"5","key":"11023_CR69","first-page":"1115","volume":"26","author":"R Jalan","year":"1997","unstructured":"Jalan R, Forrest EH, Stanley AJ, Redhead DN, Forbes J, Dillon JF, et al. A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices. Hepatology 1997;26(5):1115\u20131122","journal-title":"Hepatology"},{"issue":"3","key":"11023_CR70","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1053\/gast.1996.v110.pm8608893","volume":"110","author":"J Cabrera","year":"1996","unstructured":"Cabrera J, Maynar M, Granados R, Gorriz E, Reyes R, Pulido-Duque JM, et al. Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage. Gastroenterology 1996;110(3):832\u2013839","journal-title":"Gastroenterology"},{"issue":"4","key":"11023_CR71","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.transproceed.2004.03.117","volume":"36","author":"RF Silva","year":"2004","unstructured":"Silva RF, Arroyo PC Jr., Duca WJ, Silva AA, Reis LF, Cabral CM, et al. Complications following transjugular intrahepatic portosystemic shunt: a retrospective analysis. Transplant Proc 2004;36(4):926\u2013928","journal-title":"Transplant Proc"},{"key":"11023_CR72","doi-asserted-by":"crossref","unstructured":"Summary of recommendation statements. Kidney Int Suppl (2011) 2012;2(1):8\u201312","DOI":"10.1038\/kisup.2012.7"},{"issue":"25","key":"11023_CR73","doi-asserted-by":"publisher","first-page":"5780","DOI":"10.3748\/wjg.v22.i25.5780","volume":"22","author":"EW Lee","year":"2016","unstructured":"Lee EW, Kuei A, Saab S, Busuttil RW, Durazo F, Han SH, et al. Nationwide trends and predictors of inpatient mortality in 83884 transjugular intrahepatic portosystemic shunt. World J Gastroenterol 2016;22(25):5780\u20135789","journal-title":"World J Gastroenterol"},{"issue":"4","key":"11023_CR74","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jvir.2007.11.011","volume":"19","author":"ZJ Haskal","year":"2008","unstructured":"Haskal ZJ, Radhakrishnan J. Transjugular intrahepatic portosystemic shunts in hemodialysis-dependent patients and patients with advanced renal insufficiency: safety, caution, and encephalopathy. J Vasc Interv Radiol 2008;19(4):516\u2013520","journal-title":"J Vasc Interv Radiol"},{"issue":"11","key":"11023_CR75","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1111\/j.1572-0241.2008.02102.x","volume":"103","author":"O Riggio","year":"2008","unstructured":"Riggio O, Angeloni S, Salvatori FM, De Santis A, Cerini F, Farcomeni A, et al. Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts. Am J Gastroenterol 2008;103(11):2738\u20132746","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"11023_CR76","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1111\/j.1478-3231.2008.01734.x","volume":"28","author":"B Appenrodt","year":"2008","unstructured":"Appenrodt B, Wolf A, Grunhage F, Trebicka J, Schepke M, Rabe C, et al. Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study. Liver Int 2008;28(7):1019\u20131025","journal-title":"Liver Int"},{"issue":"2","key":"11023_CR77","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1097\/MCG.0b013e31829ae376","volume":"48","author":"H Hamdy","year":"2014","unstructured":"Hamdy H, ElBaz AA, Hassan A, Hassanin O. Comparison of midodrine and albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients: a randomized pilot study. J Clin Gastroenterol 2014;48(2):184\u2013188","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"11023_CR78","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1365-2796.2006.01654.x","volume":"260","author":"V Singh","year":"2006","unstructured":"Singh V, Kumar B, Nain CK, Singh B, Sharma N, Bhalla A, et al. Noradrenaline and albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized pilot study. J Intern Med 2006;260(1):62\u201368","journal-title":"J Intern Med"},{"issue":"1 Pt 2","key":"11023_CR79","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1440-1746.2006.04182.x","volume":"21","author":"V Singh","year":"2006","unstructured":"Singh V, Kumar R, Nain CK, Singh B, Sharma AK. Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study. J Gastroenterol Hepatol 2006;21(1 Pt 2):303\u2013307","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"11023_CR80","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.jhep.2022.06.001","volume":"77","author":"European Association for the Study of the Liver","year":"2022","unstructured":"European Association for the Study of the Liver. EASL clinical practice guidelines on the management of hepatic encephalopathy. J Hepatol 2022;77(3):807\u2013824","journal-title":"J Hepatol"},{"issue":"3","key":"11023_CR81","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1007\/BF02282344","volume":"41","author":"O Riggio","year":"1996","unstructured":"Riggio O, Merlli M, Pedretti G, Servi R, Meddi P, Lionetti R, et al. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Incidence and risk factors. Dig Dis Sci 1996;41(3):578\u2013584","journal-title":"Dig Dis Sci"},{"issue":"2","key":"11023_CR82","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jvir.2018.08.023","volume":"30","author":"L Zuo","year":"2019","unstructured":"Zuo L, Lv Y, Wang Q, Yin Z, Wang Z, He C, et al. Early-recurrent overt hepatic encephalopathy is associated with reduced survival in cirrhotic patients after transjugular intrahepatic portosystemic shunt creation. J Vasc Interv Radiol 2019;30(2):148\u2013153.e2","journal-title":"J Vasc Interv Radiol"},{"issue":"10","key":"11023_CR83","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.3748\/wjg.v20.i10.2704","volume":"20","author":"M Bai","year":"2014","unstructured":"Bai M, Qi XS, Yang ZP, Yang M, Fan DM, Han GH. TIPS improves liver transplantation-free survival in cirrhotic patients with refractory ascites: an updated meta-analysis. World J Gastroenterol 2014;20(10):2704\u20132714","journal-title":"World J Gastroenterol"},{"issue":"6","key":"11023_CR84","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/qjmed\/hcn037","volume":"101","author":"S Masson","year":"2008","unstructured":"Masson S, Mardini HA, Rose JD, Record CO. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt insertion: a decade of experience. QJM 2008;101(6):493\u2013501","journal-title":"QJM"},{"issue":"25","key":"11023_CR85","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1056\/NEJMoa0910102","volume":"362","author":"JC Garcia-Pagan","year":"2010","unstructured":"Garcia-Pagan JC, Caca K, Bureau C, Laleman W, Appenrodt B, Luca A, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med 2010;362(25):2370\u20132379","journal-title":"N Engl J Med"},{"issue":"8","key":"11023_CR86","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/S2468-1253(19)30090-1","volume":"4","author":"Y Lv","year":"2019","unstructured":"Lv Y, Yang Z, Liu L, Li K, He C, Wang Z, et al. Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trial. Lancet Gastroenterol Hepatol 2019;4(8):587\u2013598","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"11023_CR87","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jhep.2012.08.020","volume":"58","author":"JC Garcia-Pagan","year":"2013","unstructured":"Garcia-Pagan JC, Di Pascoli M, Caca K, Laleman W, Bureau C, Appenrodt B, et al. Use of early-TIPS for high-risk variceal bleeding: results of a post-RCT surveillance study. J Hepatol 2013;58(1):45\u201350","journal-title":"J Hepatol"},{"issue":"2","key":"11023_CR88","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1053\/j.gastro.2003.11.016","volume":"126","author":"C Bureau","year":"2004","unstructured":"Bureau C, Garcia-Pagan JC, Otal P, Pomier-Layrargues G, Chabbert V, Cortez C, et al. Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study. Gastroenterology 2004;126(2):469\u2013475","journal-title":"Gastroenterology"},{"issue":"11","key":"11023_CR89","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1111\/j.1440-1746.2010.06400.x","volume":"25","author":"Z Yang","year":"2010","unstructured":"Yang Z, Han G, Wu Q, Ye X, Jin Z, Yin Z, et al. Patency and clinical outcomes of transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stents versus bare stents: a meta-analysis. J Gastroenterol Hepatol 2010;25(11):1718\u20131725","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"11023_CR90","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1111\/j.1440-1746.2011.06663.x","volume":"26","author":"M Bai","year":"2011","unstructured":"Bai M, Qi X, Yang Z, Yin Z, Nie Y, Yuan S, et al. Predictors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: a systematic review. J Gastroenterol Hepatol 2011;26(6):943\u2013951","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"11023_CR91","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/hep.27210","volume":"60","author":"H Vilstrup","year":"2014","unstructured":"Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen KD, et al. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology 2014;60(2):715\u2013735","journal-title":"Hepatology"},{"issue":"5","key":"11023_CR92","doi-asserted-by":"publisher","first-page":"633","DOI":"10.7326\/M20-0202","volume":"174","author":"C Bureau","year":"2021","unstructured":"Bureau C, Thabut D, Jezequel C, Archambeaud I, D\u2019Alteroche L, Dharancy S, et al. The use of rifaximin in the prevention of overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled trial. Ann Intern Med 2021;174(5):633\u2013640","journal-title":"Ann Intern Med"},{"issue":"1","key":"11023_CR93","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11901-015-0251-0","volume":"14","author":"S Allampati","year":"2015","unstructured":"Allampati S, Raheem SA, Mullen KD. Covert hepatic encephalopathy: how aggressive should we be with diagnosis and management? Curr Hepatol Rep 2015;14(1):19\u201324","journal-title":"Curr Hepatol Rep"},{"issue":"2","key":"11023_CR94","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/hep.26684","volume":"59","author":"P Berlioux","year":"2014","unstructured":"Berlioux P, Robic MA, Poirson H, Metivier S, Otal P, Barret C, et al. Pre-transjugular intrahepatic portosystemic shunts (TIPS) prediction of post-TIPS overt hepatic encephalopathy: the critical flicker frequency is more accurate than psychometric tests. Hepatology 2014;59(2):622\u2013629","journal-title":"Hepatology"},{"issue":"1","key":"11023_CR95","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s00270-018-2040-y","volume":"42","author":"R Miraglia","year":"2019","unstructured":"Miraglia R, Maruzzelli L, Di Piazza A, Mamone G, Caruso S, Gentile G, et al. Transjugular intrahepatic portosystemic shunt using the new Gore Viatorr controlled expansion endoprosthesis: prospective, single-center, preliminary experience. Cardiovasc Intervent Radiol 2019;42(1):78\u201386","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"3","key":"11023_CR96","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.jhep.2017.05.006","volume":"67","author":"Q Wang","year":"2017","unstructured":"Wang Q, Lv Y, Bai M, Wang Z, Liu H, He C, et al. Eight millimetre covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleeding. J Hepatol 2017;67(3):508\u2013516","journal-title":"J Hepatol"},{"issue":"5","key":"11023_CR97","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s00270-019-02162-4","volume":"42","author":"X Luo","year":"2019","unstructured":"Luo X, Wang X, Zhu Y, Xi X, Zhao Y, Yang J, et al. Clinical efficacy of transjugular intrahepatic portosystemic shunt created with expanded polytetrafluoroethylene-covered stent-grafts: 8-mm versus 10-mm. Cardiovasc Intervent Radiol 2019;42(5):737\u2013743","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"11","key":"11023_CR98","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1136\/gut.2005.089482","volume":"55","author":"N Kochar","year":"2006","unstructured":"Kochar N, Tripathi D, Ireland H, Redhead DN, Hayes PC. Transjugular intrahepatic portosystemic stent shunt (TIPSS) modification in the management of post-TIPSS refractory hepatic encephalopathy. Gut 2006;55(11):1617\u20131623","journal-title":"Gut"},{"key":"11023_CR99","volume-title":"Consent to Medical and Healthcare Treatment Manual","author":"Corporate Governance and Risk Management","year":"2023","unstructured":"Corporate Governance and Risk Management. Consent to Medical and Healthcare Treatment Manual. Sydney: NSW Ministry of Health; 2023"},{"key":"11023_CR100","unstructured":"Australian Commission on Safety and Quality in Health Care. Fact Sheet for Clinicians: Informed Consent in Health Care. Sydney: ACSQHC; 2020."},{"key":"11023_CR101","unstructured":"Informed consent and presumption of capacity. 2023 [cited 22 February 2025]. In: Mental Health and Wellbeing Act 2022 Handbook [Internet]. Melbourne: Victorian Department of Health, [cited 22 February 2025]. https:\/\/www.health.vic.gov.au\/mental-health-and-wellbeing-act-handbook\/supported-decision-making\/informed-consent-and-presumption"},{"key":"11023_CR102","unstructured":"Clinical Excellence Queensland. Guide to informed Decision-Making in Health Care, version 2.5. Brisbane: Queensland Health; 2024"},{"key":"11023_CR103","unstructured":"Department of Health. Consent to Treatment Policy (MP 0175\/22). Perth: Government of Western Australia; 2024"},{"key":"11023_CR104","unstructured":"SA Health. Consent to Medical Treatment and Healthcare. Adelaide: Government of South Australia; 2025"},{"key":"11023_CR105","unstructured":"Regulation, Licensing and Accreditation Unit. Consent Requirements for Medical Treatment (Advisory Notice 6\/20). Hobart: Department of Health; 2020"},{"issue":"1","key":"11023_CR106","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/hep.31646","volume":"73","author":"PG Northup","year":"2021","unstructured":"Northup PG, Garcia-Pagan JC, Garcia-Tsao G, Intagliata NM, Superina RA, Roberts LN, et al. Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the American Association for the Study of Liver Diseases. Hepatology 2021;73(1):366\u2013413","journal-title":"Hepatology"},{"issue":"2","key":"11023_CR107","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/hep.28148","volume":"63","author":"L De Pietri","year":"2016","unstructured":"De Pietri L, Bianchini M, Montalti R, De Maria N, Di Maira T, Begliomini B, et al. Thrombelastography-guided blood product use before invasive procedures in cirrhosis with severe coagulopathy: a randomized, controlled trial. Hepatology 2016;63(2):566\u2013573","journal-title":"Hepatology"},{"key":"11023_CR108","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ejim.2016.11.007","volume":"38","author":"G Napolitano","year":"2017","unstructured":"Napolitano G, Iacobellis A, Merla A, Niro G, Valvano MR, Terracciano F, et al. Bleeding after invasive procedures is rare and unpredicted by platelet counts in cirrhotic patients with thrombocytopenia. Eur J Intern Med 2017;38:79\u201382","journal-title":"Eur J Intern Med"},{"issue":"2","key":"11023_CR109","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1056\/NEJMra1011170","volume":"365","author":"A Tripodi","year":"2011","unstructured":"Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease. N Engl J Med 2011;365(2):147\u2013156","journal-title":"N Engl J Med"},{"issue":"3","key":"11023_CR110","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/hep.20569","volume":"41","author":"A Tripodi","year":"2005","unstructured":"Tripodi A, Salerno F, Chantarangkul V, Clerici M, Cazzaniga M, Primignani M, et al. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology 2005;41(3):553\u2013558","journal-title":"Hepatology"},{"key":"11023_CR111","doi-asserted-by":"crossref","unstructured":"Segal JB, Dzik WH, Transfusion Medicine\/Hemostasis Clinical Trials Network. Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review. Transfusion 2005;45(9):1413\u201325.","DOI":"10.1111\/j.1537-2995.2005.00546.x"},{"issue":"5","key":"11023_CR112","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.jhep.2014.01.015","volume":"60","author":"JM Perarnau","year":"2014","unstructured":"Perarnau JM, Le Gouge A, Nicolas C, d\u2019Alteroche L, Borentain P, Saliba F, et al. Covered vs. uncovered stents for transjugular intrahepatic portosystemic shunt: a randomized controlled trial. J Hepatol 2014;60(5):962\u2013968","journal-title":"J Hepatol"},{"issue":"2","key":"11023_CR113","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0212658","volume":"14","author":"X Luo","year":"2019","unstructured":"Luo X, Zhao M, Wang X, Jiang M, Yu J, Li X, et al. Long-term patency and clinical outcome of the transjugular intrahepatic portosystemic shunt using the expanded polytetrafluoroethylene stent-graft. PLoS ONE 2019;14(2):e0212658","journal-title":"PLoS ONE"},{"issue":"2","key":"11023_CR114","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/j.1572-0241.2004.04056.x","volume":"99","author":"S Angeloni","year":"2004","unstructured":"Angeloni S, Merli M, Salvatori FM, De Santis A, Fanelli F, Pepino D, et al. Polytetrafluoroethylene-covered stent grafts for TIPS procedure: 1-year patency and clinical results. Am J Gastroenterol 2004;99(2):280\u2013285","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"11023_CR115","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ejrad.2004.10.007","volume":"55","author":"J Barrio","year":"2005","unstructured":"Barrio J, Ripoll C, Banares R, Echenagusia A, Catalina MV, Camunez F, et al. Comparison of transjugular intrahepatic portosystemic shunt dysfunction in PTFE-covered stent-grafts versus bare stents. Eur J Radiol 2005;55(1):120\u2013124","journal-title":"Eur J Radiol"},{"issue":"11","key":"11023_CR116","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1097\/01.RVI.0000137434.19522.E5","volume":"15","author":"JP Charon","year":"2004","unstructured":"Charon JP, Alaeddin FH, Pimpalwar SA, Fay DM, Olliff SP, Jackson RW, et al. Results of a retrospective multicenter trial of the Viatorr expanded polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt creation. J Vasc Interv Radiol 2004;15(11):1219\u20131230","journal-title":"J Vasc Interv Radiol"},{"issue":"3","key":"11023_CR117","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/01.RVI.0000116194.44877.C1","volume":"15","author":"KA Hausegger","year":"2004","unstructured":"Hausegger KA, Karnel F, Georgieva B, Tauss J, Portugaller H, Deutschmann H, et al. Transjugular intrahepatic portosystemic shunt creation with the Viatorr expanded polytetrafluoroethylene-covered stent-graft. J Vasc Interv Radiol 2004;15(3):239\u2013248","journal-title":"J Vasc Interv Radiol"},{"issue":"1","key":"11023_CR118","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2214\/ajr.178.1.1780141","volume":"178","author":"P Otal","year":"2002","unstructured":"Otal P, Smayra T, Bureau C, Peron JM, Chabbert V, Chemla P, et al. Preliminary results of a new expanded-polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt procedures. AJR Am J Roentgenol 2002;178(1):141\u2013147","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"11023_CR119","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jhep.2010.02.033","volume":"53","author":"O Riggio","year":"2010","unstructured":"Riggio O, Ridola L, Angeloni S, Cerini F, Pasquale C, Attili AF, et al. Clinical efficacy of transjugular intrahepatic portosystemic shunt created with covered stents with different diameters: results of a randomized controlled trial. J Hepatol 2010;53(2):267\u2013272","journal-title":"J Hepatol"},{"issue":"3","key":"11023_CR120","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1097\/00042737-200603000-00001","volume":"18","author":"D Tripathi","year":"2006","unstructured":"Tripathi D, Ferguson J, Barkell H, Macbeth K, Ireland H, Redhead DN, et al. Improved clinical outcome with transjugular intrahepatic portosystemic stent-shunt utilizing polytetrafluoroethylene-covered stents. Eur J Gastroenterol Hepatol 2006;18(3):225\u2013232","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"7","key":"11023_CR121","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1089\/lap.2017.0560","volume":"28","author":"T Triantafyllou","year":"2018","unstructured":"Triantafyllou T, Aggarwal P, Gupta E, Svetanoff WJ, Bhirud DP, Singhal S. Polytetrafluoroethylene-covered stent graft versus bare stent in transjugular intrahepatic portosystemic shunt: systematic review and meta-analysis. J Laparoendosc Adv Surg Tech A 2018;28(7):867\u2013879","journal-title":"J Laparoendosc Adv Surg Tech A"},{"issue":"3","key":"11023_CR122","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1148\/radiology.146.3.6600846","volume":"146","author":"R Uflacker","year":"1983","unstructured":"Uflacker R. Percutaneous transhepatic obliteration of gastroesophageal varices using absolute alcohol. Radiology 1983;146(3):621\u2013625","journal-title":"Radiology"},{"issue":"3","key":"11023_CR123","first-page":"385","volume":"28","author":"M Shounak","year":"2015","unstructured":"Shounak M, Vimal R, Colin S, David IS. A retrospective analysis of the impact of diastolic dysfunction on one-year mortality after transjugular intrahepatic porto-systemic shunt, liver transplantation and non-transplant abdominal surgery in patients with cirrhosis. Ann Gastroenterol 2015;28(3):385\u2013390","journal-title":"Ann Gastroenterol"},{"issue":"6","key":"11023_CR124","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1136\/gut.2006.102467","volume":"56","author":"M Cazzaniga","year":"2007","unstructured":"Cazzaniga M, Salerno F, Pagnozzi G, Dionigi E, Visentin S, Cirello I, et al. Diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosystemic shunt. Gut 2007;56(6):869\u2013875","journal-title":"Gut"},{"issue":"6","key":"11023_CR125","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1053\/j.gastro.2017.01.011","volume":"152","author":"G Silva-Junior","year":"2017","unstructured":"Silva-Junior G, Turon F, Baiges A, Cerda E, Garcia-Criado A, Blasi A, et al. Timing affects measurement of portal pressure gradient after placement of transjugular intrahepatic portosystemic shunts in patients with portal hypertension. Gastroenterology 2017;152(6):1358\u20131365","journal-title":"Gastroenterology"},{"issue":"6","key":"11023_CR126","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1002\/hep.23612","volume":"51","author":"V La Mura","year":"2010","unstructured":"La Mura V, Abraldes JG, Berzigotti A, Erice E, Flores-Arroyo A, Garcia-Pagan JC, et al. Right atrial pressure is not adequate to calculate portal pressure gradient in cirrhosis: a clinical-hemodynamic correlation study. Hepatology 2010;51(6):2108\u20132116","journal-title":"Hepatology"},{"issue":"4","key":"11023_CR127","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.2214\/AJR.04.1831","volume":"186","author":"D Lake","year":"2006","unstructured":"Lake D, Guimaraes M, Ackerman S, Hannegan C, Schonholz C, Selby JB, et al. Comparative results of doppler sonography after TIPS using covered and bare stents. AJR Am J Roentgenol 2006;186(4):1138\u20131143","journal-title":"AJR Am J Roentgenol"},{"issue":"12","key":"11023_CR128","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1111\/j.1572-0241.2005.00290.x","volume":"100","author":"JG Abraldes","year":"2005","unstructured":"Abraldes JG, Gilabert R, Turnes J, Nicolau C, Berzigotti A, Aponte J, et al. Utility of color doppler ultrasonography predicting tips dysfunction. Am J Gastroenterol 2005;100(12):2696\u20132701","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"11023_CR129","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S1051-0443(97)70607-9","volume":"8","author":"ZJ Haskal","year":"1997","unstructured":"Haskal ZJ, Carroll JW, Jacobs JE, Arger PH, Yin D, Coleman BG, et al. Sonography of transjugular intrahepatic portosystemic shunts: detection of elevated portosystemic gradients and loss of shunt function. J Vasc Interv Radiol 1997;8(4):549\u2013556","journal-title":"J Vasc Interv Radiol"},{"issue":"1","key":"11023_CR130","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2214\/ajr.165.1.7785564","volume":"165","author":"MC Foshager","year":"1995","unstructured":"Foshager MC, Ferral H, Nazarian GK, Castaneda-Zuniga WR, Letourneau JG. Duplex sonography after transjugular intrahepatic portosystemic shunts (TIPS): normal hemodynamic findings and efficacy in predicting shunt patency and stenosis. AJR Am J Roentgenol 1995;165(1):1\u20137","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"11023_CR131","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.2214\/AJR.07.3534","volume":"191","author":"M Cura","year":"2008","unstructured":"Cura M, Cura A, Suri R, El-Merhi F, Lopera J, Kroma G. Causes of TIPS dysfunction. AJR Am J Roentgenol 2008;191(6):1751\u20131757","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"11023_CR132","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1148\/radiology.207.3.9609891","volume":"207","author":"RS Saxon","year":"1998","unstructured":"Saxon RS, Ross PL, Mendel-Hartvig J, Barton RE, Benner K, Flora K, et al. Transjugular intrahepatic portosystemic shunt patency and the importance of stenosis location in the development of recurrent symptoms. Radiology 1998;207(3):683\u2013693","journal-title":"Radiology"},{"issue":"6","key":"11023_CR133","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1002\/hep.28360","volume":"63","author":"A Escorsell","year":"2016","unstructured":"Escorsell A, Pavel O, Cardenas A, Morillas R, Llop E, Villanueva C, et al. Esophageal balloon tamponade versus esophageal stent in controlling acute refractory variceal bleeding: a multicenter randomized, controlled trial. Hepatology 2016;63(6):1957\u20131967","journal-title":"Hepatology"},{"issue":"2","key":"11023_CR134","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1053\/j.gastro.2013.10.018","volume":"146","author":"E Reverter","year":"2014","unstructured":"Reverter E, Tandon P, Augustin S, Turon F, Casu S, Bastiampillai R, et al. A MELD-based model to determine risk of mortality among patients with acute variceal bleeding. Gastroenterology 2014;146(2):412\u2013419.e3","journal-title":"Gastroenterology"},{"issue":"4","key":"11023_CR135","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/0016-5085(81)90144-X","volume":"80","author":"DY Graham","year":"1981","unstructured":"Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology 1981;80(4):800\u2013809","journal-title":"Gastroenterology"},{"issue":"1","key":"11023_CR136","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/hep.28906","volume":"65","author":"G Garcia-Tsao","year":"2017","unstructured":"Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the Study of Liver Diseases. Hepatology 2017;65(1):310\u2013335","journal-title":"Hepatology"},{"issue":"4","key":"11023_CR137","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1002\/hep.31913","volume":"74","author":"A Walter","year":"2021","unstructured":"Walter A, Rudler M, Olivas P, Moga L, Trepo E, Robic MA, et al. Combination of model for end-stage liver disease and lactate predicts death in patients treated with salvage transjugular intrahepatic portosystemic shunt for refractory variceal bleeding. Hepatology 2021;74(4):2085\u20132101","journal-title":"Hepatology"},{"issue":"1","key":"11023_CR138","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1053\/j.gastro.2020.09.026","volume":"160","author":"O Nicoara-Farcau","year":"2021","unstructured":"Nicoara-Farcau O, Han G, Rudler M, Angrisani D, Monescillo A, Torres F, et al. Effects of early placement of transjugular portosystemic shunts in patients with high-risk acute variceal bleeding: a meta-analysis of individual patient data. Gastroenterology 2021;160(1):193\u2013205.e10","journal-title":"Gastroenterology"},{"issue":"4","key":"11023_CR139","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.jhep.2020.01.008","volume":"72","author":"M Magaz","year":"2020","unstructured":"Magaz M, Baiges A, Hernandez-Gea V. Precision medicine in variceal bleeding: are we there yet? J Hepatol 2020;72(4):774\u2013784","journal-title":"J Hepatol"},{"issue":"1","key":"11023_CR140","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/apt.15797","volume":"52","author":"PDJ Dunne","year":"2020","unstructured":"Dunne PDJ, Sinha R, Stanley AJ, Lachlan N, Ireland H, Shams A, et al. Randomised clinical trial: standard of care versus early-transjugular intrahepatic porto-systemic shunt (TIPSS) in patients with cirrhosis and oesophageal variceal bleeding. Aliment Pharmacol Ther 2020;52(1):98\u2013106","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"11023_CR141","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1136\/gutjnl-2022-326975","volume":"72","author":"M Rudler","year":"2023","unstructured":"Rudler M, Hernandez-Gea V, Procopet BD, Giraldez A, Amitrano L, Villanueva C, et al. Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding. Gut 2023;72(4):749\u2013758","journal-title":"Gut"},{"issue":"5","key":"11023_CR142","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.jhep.2020.04.024","volume":"73","author":"J Trebicka","year":"2020","unstructured":"Trebicka J, Gu W, Ibanez-Samaniego L, Hernandez-Gea V, Pitarch C, Garcia E, et al. Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS. J Hepatol 2020;73(5):1082\u20131091","journal-title":"J Hepatol"},{"issue":"3","key":"11023_CR143","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.jhep.2023.04.028","volume":"79","author":"H Larrue","year":"2023","unstructured":"Larrue H, D\u2019Amico G, Olivas P, Lv Y, Bucsics T, Rudler M, et al. TIPS prevents further decompensation and improves survival in patients with cirrhosis and portal hypertension in an individual patient data meta-analysis. J Hepatol 2023;79(3):692\u2013703","journal-title":"J Hepatol"},{"issue":"3","key":"11023_CR144","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1053\/j.gastro.2015.05.011","volume":"149","author":"T Sauerbruch","year":"2015","unstructured":"Sauerbruch T, Mengel M, Dollinger M, Zipprich A, Rossle M, Panther E, et al. Prevention of rebleeding from esophageal varices in patients with cirrhosis receiving small-diameter stents versus hemodynamically controlled medical therapy. Gastroenterology 2015;149(3):660\u2013668.e1","journal-title":"Gastroenterology"},{"issue":"2","key":"11023_CR145","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/hep.28318","volume":"63","author":"IL Holster","year":"2016","unstructured":"Holster IL, Tjwa ET, Moelker A, Wils A, Hansen BE, Vermeijden JR, et al. Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy\u00a0+\u00a0beta-blocker for prevention of variceal rebleeding. Hepatology 2016;63(2):581\u2013589","journal-title":"Hepatology"},{"issue":"6","key":"11023_CR146","doi-asserted-by":"publisher","first-page":"704","DOI":"10.5009\/gnl17515","volume":"12","author":"G Gimm","year":"2018","unstructured":"Gimm G, Chang Y, Kim HC, Shin A, Cho EJ, Lee JH, et al. Balloon-occluded retrograde transvenous obliteration versus transjugular intrahepatic portosystemic shunt for the management of gastric variceal bleeding. Gut Liver 2018;12(6):704\u2013713","journal-title":"Gut Liver"},{"issue":"2","key":"11023_CR147","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3348\/kjr.2003.4.2.109","volume":"4","author":"YH Choi","year":"2003","unstructured":"Choi YH, Yoon CJ, Park JH, Chung JW, Kwon JW, Choi GM. Balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding: its feasibility compared with transjugular intrahepatic portosystemic shunt. Korean J Radiol 2003;4(2):109\u2013116","journal-title":"Korean J Radiol"},{"issue":"2","key":"11023_CR148","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3348\/kjr.2017.18.2.345","volume":"18","author":"SK Kim","year":"2017","unstructured":"Kim SK, Lee KA, Sauk S, Korenblat K. Comparison of transjugular intrahepatic portosystemic shunt with covered stent and balloon-occluded retrograde transvenous obliteration in managing isolated gastric varices. Korean J Radiol 2017;18(2):345\u2013354","journal-title":"Korean J Radiol"},{"issue":"8","key":"11023_CR149","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1111\/jgh.13729","volume":"32","author":"SJ Lee","year":"2017","unstructured":"Lee SJ, Kim SU, Kim MD, Kim YH, Kim GM, Park SI, et al. Comparison of treatment outcomes between balloon-occluded retrograde transvenous obliteration and transjugular intrahepatic portosystemic shunt for gastric variceal bleeding hemostasis. J Gastroenterol Hepatol 2017;32(8):1487\u20131494","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"11023_CR150","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jvir.2013.12.001","volume":"25","author":"SS Sabri","year":"2014","unstructured":"Sabri SS, Abi-Jaoudeh N, Swee W, Saad WE, Turba UC, Caldwell SH, et al. Short-term rebleeding rates for isolated gastric varices managed by transjugular intrahepatic portosystemic shunt versus balloon-occluded retrograde transvenous obliteration. J Vasc Interv Radiol 2014;25(3):355\u2013361","journal-title":"J Vasc Interv Radiol"},{"issue":"4","key":"11023_CR151","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1111\/jgh.13248","volume":"31","author":"YB Wang","year":"2016","unstructured":"Wang YB, Zhang JY, Gong JP, Zhang F, Zhao Y. Balloon-occluded retrograde transvenous obliteration versus transjugular intrahepatic portosystemic shunt for treatment of gastric varices due to portal hypertension: a meta-analysis. J Gastroenterol Hepatol 2016;31(4):727\u2013733","journal-title":"J Gastroenterol Hepatol"},{"issue":"7","key":"11023_CR152","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1097\/MCG.0000000000001275","volume":"54","author":"S Paleti","year":"2020","unstructured":"Paleti S, Nutalapati V, Fathallah J, Jeepalyam S, Rustagi T. Balloon-occluded retrograde transvenous obliteration (BRTO) versus transjugular intrahepatic portosystemic shunt (TIPS) for treatment of gastric varices because of portal hypertension: a systematic review and meta-analysis. J Clin Gastroenterol 2020;54(7):655\u2013660","journal-title":"J Clin Gastroenterol"},{"issue":"2","key":"11023_CR153","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/MCG.0000000000001305","volume":"55","author":"Q Yu","year":"2021","unstructured":"Yu Q, Liu C, Raissi D. Balloon-occluded retrograde transvenous obliteration versus transjugular intrahepatic portosystemic shunt for gastric varices: a meta-analysis. J Clin Gastroenterol 2021;55(2):147\u2013158","journal-title":"J Clin Gastroenterol"},{"issue":"6","key":"11023_CR154","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100717","volume":"5","author":"A Escorsell","year":"2023","unstructured":"Escorsell A, Garcia-Pagan JC, Alvarado-Tapia E, Aracil C, Masnou H, Villanueva C, et al. Pre-emptive TIPS for the treatment of bleeding from gastric fundal varices: results of a randomised controlled trial. JHEP Rep 2023;5(6):100717","journal-title":"JHEP Rep"},{"issue":"12","key":"11023_CR155","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1111\/j.1572-0241.2003.08769.x","volume":"98","author":"S Mahadeva","year":"2003","unstructured":"Mahadeva S, Bellamy MC, Kessel D, Davies MH, Millson CE. Cost-effectiveness of N-butyl-2-cyanoacrylate (histoacryl) glue injections versus transjugular intrahepatic portosystemic shunt in the management of acute gastric variceal bleeding. Am J Gastroenterol 2003;98(12):2688\u20132693","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"11023_CR156","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.gie.2009.03.1169","volume":"70","author":"NJ Procaccini","year":"2009","unstructured":"Procaccini NJ, Al-Osaimi AM, Northup P, Argo C, Caldwell SH. Endoscopic cyanoacrylate versus transjugular intrahepatic portosystemic shunt for gastric variceal bleeding: a single-center U.S. analysis. Gastrointest Endosc 2009;70(5):881\u2013887","journal-title":"Gastrointest Endosc"},{"issue":"8","key":"11023_CR157","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1055\/s-2007-966591","volume":"39","author":"GH Lo","year":"2007","unstructured":"Lo GH, Liang HL, Chen WC, Chen MH, Lai KH, Hsu PI, et al. A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding. Endoscopy 2007;39(8):679\u2013685","journal-title":"Endoscopy"},{"key":"11023_CR158","unstructured":"NICE. Cirrhosis in Over 16s: Assessment and Management. London: National Institute for Health and Care Excellence: Guidelines; 2016"},{"issue":"4","key":"11023_CR159","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.dld.2018.01.123","volume":"50","author":"T Song","year":"2018","unstructured":"Song T, Rossle M, He F, Liu F, Guo X, Qi X. Transjugular intrahepatic portosystemic shunt for hepatorenal syndrome: a systematic review and meta-analysis. Dig Liver Dis 2018;50(4):323\u2013330","journal-title":"Dig Liver Dis"},{"issue":"9","key":"11023_CR160","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1016\/j.jvir.2015.04.017","volume":"26","author":"J Tsauo","year":"2015","unstructured":"Tsauo J, Weng N, Ma H, Jiang M, Zhao H, Li X. Role of transjugular intrahepatic portosystemic shunts in the management of hepatopulmonary syndrome: a systemic literature review. J Vasc Interv Radiol 2015;26(9):1266\u20131271","journal-title":"J Vasc Interv Radiol"},{"issue":"6","key":"11023_CR161","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.1007\/s00330-018-5840-1","volume":"29","author":"J Tsauo","year":"2019","unstructured":"Tsauo J, Zhao H, Zhang X, Ma H, Jiang M, Weng N, et al. Changes in arterial oxygenation after portal decompression in Budd\u2013Chiari syndrome patients with hepatopulmonary syndrome. Eur Radiol 2019;29(6):3273\u20133280","journal-title":"Eur Radiol"},{"issue":"49","key":"11023_CR162","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000009080","volume":"96","author":"H Zhao","year":"2017","unstructured":"Zhao H, Liu F, Yue Z, Wang L, Fan Z, He F. Clinical efficacy of transjugular intrahepatic portosystemic shunt in the treatment of hepatopulmonary syndrome. Medicine (Baltimore) 2017;96(49):e9080","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"11023_CR163","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1053\/j.gastro.2008.05.051","volume":"135","author":"JC Garcia-Pagan","year":"2008","unstructured":"Garcia-Pagan JC, Heydtmann M, Raffa S, Plessier A, Murad S, Fabris F, et al. TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 patients. Gastroenterology 2008;135(3):808\u2013815","journal-title":"Gastroenterology"},{"issue":"1","key":"11023_CR164","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/hep.28547","volume":"64","author":"J Bissonnette","year":"2016","unstructured":"Bissonnette J, Garcia-Pagan JC, Albillos A, Turon F, Ferreira C, Tellez L, et al. Role of the transjugular intrahepatic portosystemic shunt in the management of severe complications of portal hypertension in idiopathic noncirrhotic portal hypertension. Hepatology 2016;64(1):224\u2013231","journal-title":"Hepatology"},{"issue":"1","key":"11023_CR165","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s10620-010-1278-2","volume":"56","author":"CE Eapen","year":"2011","unstructured":"Eapen CE, Nightingale P, Hubscher SG, Lane PJ, Plant T, Velissaris D, et al. Non-cirrhotic intrahepatic portal hypertension: associated gut diseases and prognostic factors. Dig Dis Sci 2011;56(1):227\u2013235","journal-title":"Dig Dis Sci"},{"issue":"12","key":"11023_CR166","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1111\/j.1365-2036.2012.05112.x","volume":"35","author":"JN Schouten","year":"2012","unstructured":"Schouten JN, Nevens F, Hansen B, Laleman W, van den Born M, Komuta M, et al. Idiopathic noncirrhotic portal hypertension is associated with poor survival: results of a long-term cohort study. Aliment Pharmacol Ther 2012;35(12):1424\u20131433","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"11023_CR167","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1002\/hep.26904","volume":"59","author":"S Siramolpiwat","year":"2014","unstructured":"Siramolpiwat S, Seijo S, Miquel R, Berzigotti A, Garcia-Criado A, Darnell A, et al. Idiopathic portal hypertension: natural history and long-term outcome. Hepatology 2014;59(6):2276\u20132285","journal-title":"Hepatology"},{"issue":"5","key":"11023_CR168","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/MEG.0000000000001067","volume":"30","author":"D Regnault","year":"2018","unstructured":"Regnault D, d\u2019Alteroche L, Nicolas C, Dujardin F, Ayoub J, Perarnau JM. Ten-year experience of transjugular intrahepatic portosystemic shunt for noncirrhotic portal hypertension. Eur J Gastroenterol Hepatol 2018;30(5):557\u2013562","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"7","key":"11023_CR169","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1111\/apt.15186","volume":"49","author":"Y Lv","year":"2019","unstructured":"Lv Y, Li K, He C, Luo B, Zhang B, Liu H, et al. TIPSS for variceal bleeding in patients with idiopathic non-cirrhotic portal hypertension: comparison with patients who have cirrhosis. Aliment Pharmacol Ther 2019;49(7):926\u2013939","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"11023_CR170","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1007\/s11605-018-4053-x","volume":"23","author":"N Tabchouri","year":"2019","unstructured":"Tabchouri N, Barbier L, Menahem B, Perarnau JM, Muscari F, Fares N, et al. Original study: transjugular intrahepatic portosystemic shunt as a bridge to abdominal surgery in cirrhotic patients. J Gastrointest Surg 2019;23(12):2383\u20132390","journal-title":"J Gastrointest Surg"},{"issue":"4","key":"11023_CR171","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1053\/he.2000.5852","volume":"31","author":"M Malinchoc","year":"2000","unstructured":"Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000;31(4):864\u2013871","journal-title":"Hepatology"},{"issue":"6","key":"11023_CR172","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1053\/j.gastro.2006.02.010","volume":"130","author":"SW Biggins","year":"2006","unstructured":"Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology 2006;130(6):1652\u20131660","journal-title":"Gastroenterology"},{"issue":"3","key":"11023_CR173","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/liv.13632","volume":"38","author":"M Rudler","year":"2018","unstructured":"Rudler M, Bureau C, Carbonell N, Mathurin P, Saliba F, Mallat A, et al. Recalibrated MELD and hepatic encephalopathy are prognostic factors in cirrhotic patients with acute variceal bleeding. Liver Int 2018;38(3):469\u2013476","journal-title":"Liver Int"},{"issue":"5","key":"11023_CR174","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1002\/hep.31199","volume":"72","author":"N Sarmast","year":"2020","unstructured":"Sarmast N, Ogola GO, Kouznetsova M, Leise MD, Bahirwani R, Maiwall R, et al. Model for end-stage liver disease-lactate and prediction of inpatient mortality in patients with chronic liver disease. Hepatology 2020;72(5):1747\u20131757","journal-title":"Hepatology"},{"issue":"7","key":"11023_CR175","doi-asserted-by":"publisher","DOI":"10.1038\/ctg.2015.31","volume":"6","author":"AJ Montano-Loza","year":"2015","unstructured":"Montano-Loza AJ, Duarte-Rojo A, Meza-Junco J, Baracos VE, Sawyer MB, Pang JX, et al. Inclusion of sarcopenia within MELD (MELD-Sarcopenia) and the prediction of mortality in patients with cirrhosis. Clin Transl Gastroenterol 2015;6(7):e102","journal-title":"Clin Transl Gastroenterol"},{"key":"11023_CR176","doi-asserted-by":"crossref","unstructured":"Kim WR, Mannalithara A, Heimbach JK, Kamath PS, Asrani SK, Biggins SW, et al. MELD 3.0: the Model for End-Stage Liver Disease updated for the modern era. Gastroenterology 2021;161(6):1887\u20131895.e4.","DOI":"10.1053\/j.gastro.2021.08.050"},{"issue":"9","key":"11023_CR177","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1053\/jlts.2002.35927","volume":"8","author":"RB Freeman Jr","year":"2002","unstructured":"Freeman RB Jr, Wiesner RH, Harper A, McDiarmid SV, Lake J, Edwards E, et al. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl 2002;8(9):851\u2013858","journal-title":"Liver Transpl"},{"issue":"2","key":"11023_CR178","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1053\/jhep.2001.22172","volume":"33","author":"PS Kamath","year":"2001","unstructured":"Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33(2):464\u2013470","journal-title":"Hepatology"},{"issue":"4","key":"11023_CR179","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.jhep.2014.11.012","volume":"62","author":"R Jalan","year":"2015","unstructured":"Jalan R, Pavesi M, Saliba F, Amoros A, Fernandez J, Holland-Fischer P, et al. The CLIF consortium acute decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure. J Hepatol 2015;62(4):831\u2013840","journal-title":"J Hepatol"},{"issue":"5","key":"11023_CR180","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.jhep.2014.06.012","volume":"61","author":"R Jalan","year":"2014","unstructured":"Jalan R, Saliba F, Pavesi M, Amoros A, Moreau R, Gines P, et al. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. J Hepatol 2014;61(5):1038\u20131047","journal-title":"J Hepatol"},{"issue":"6","key":"11023_CR181","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","volume":"33","author":"PJ Johnson","year":"2015","unstructured":"Johnson PJ, Berhane S, Kagebayashi C, Satomura S, Teng M, Reeves HL, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol 2015;33(6):550\u2013558","journal-title":"J Clin Oncol"},{"issue":"5","key":"11023_CR182","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.jhep.2010.08.025","volume":"54","author":"C Bureau","year":"2011","unstructured":"Bureau C, Metivier S, D\u2019Amico M, Peron JM, Otal P, Pagan JC, et al. Serum bilirubin and platelet count: a simple predictive model for survival in patients with refractory ascites treated by TIPS. J Hepatol 2011;54(5):901\u2013907","journal-title":"J Hepatol"},{"issue":"Suppl 1","key":"11023_CR183","first-page":"631A","volume":"62","author":"S Roayaie","year":"2015","unstructured":"Roayaie S, Jibara G, Berhane S, Tabrizian P, Park J-W, Yang J, et al. PALBI-an objective score based on platelets, albumin and bilirubin stratifies HCC patients undergoing resection and ablation better than Child\u2019s classification. Hepatology 2015;62(Suppl 1):631A\u2013632A","journal-title":"Hepatology"},{"key":"11023_CR184","doi-asserted-by":"crossref","unstructured":"Nicoar\u0103-Farc\u0103u O, Han G, Rudler M, Angrisani D, Monescillo A, Torres F, Casanovas G, Bosch J, Lv Y, Dunne PDJ, Hayes PC, Thabut D, Fan D, Hern\u00e1ndez-Gea V, Garc\u00eda-Pag\u00e1n JC; Pre-emptive TIPS Individual Data Metaanalysis, International Variceal Bleeding Study and Baveno Cooperation Study Groups. Pre-emptive TIPS in high-risk acute variceal bleeding: an updated and revised individual patient data meta-analysis. Hepatology 2024;79(3):624\u201335","DOI":"10.1097\/HEP.0000000000000613"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-025-11023-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-025-11023-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-025-11023-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T20:01:53Z","timestamp":1777320113000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-025-11023-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":184,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["11023"],"URL":"https:\/\/doi.org\/10.1007\/s12072-025-11023-x","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]},"assertion":[{"value":"6 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Golo Ahlenstiel has received speaker fees from CSL Behring, Gore and Norgine. Avik Majumdar has received speaker fees or served on advisory boards for CSL, Gilead, Norgine, Ipsen, Cook Medical and Eisai. James O\u2019Beirne has been an advisor to Surrozen Pharmaceuticals, CSL, Norgine and Roche; and has received speaker fees from CSL and Norgine. Purnima Bhat has served in unpaid positions as a member of the World Endoscopy Organization Research Committee and Chair of the World Endoscopy Organization African Outreach Committee. Jacob George is on advisory boards and has received honoraria for talks from Novo Nordisk, AstraZeneca, Roche, BMS, Pfizer, Cincera, Pharmaxis and Boehringer Mannheim. Jacinta Holmes is an advisory board member for CSL Behring. Eric Kalo has received a Western Sydney University and the Australian Government Research Training Program award. John Lubel has served as an unpaid advisory board member for CSL; received speaker fees from Norgine and Gilead; been an unpaid speaker at GP dinners sponsored by Norgine and Falk; been an invited mentor at an Australian Gastrointestinal Trials Group preceptorship event, with no personal fees received but flights and accommodation provided; been an advisory consultant and received speaker fees from Ipsen for internal staff education; received partial support from Norgine for a PhD student to travel to an international conference; received sponsorship but no speaker fees from Viatris for a GP educational event; received sponsorship from Ipsen to attend the EASL international meeting in Milan, Italy, in 2024; received a $60,000 grant from Ipsen for primary biliary cholangitis research; and received a speaker fee from Limbic. Tim Mitchell received speaker fees from Eisai in 2023 and Gilead in 2022. John Olynyk was previously a Board member and Treasurer of GESA and Chair of the Research Committee. Christopher Rogan is President of IRSA. Simone Strasser is Director of the Liver Foundation and has served on advisory boards or received speaker fees from Norgine, Roche, AstraZeneca, Ipsen, Eisai, Bayer, Sirtex, BMS, MSD, AbbVie, Gilead Sciences, Astellas, Novartis, Pfizer, CSL Behring, Dr. Falk Pharma and Chiesi. All the other authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The corresponding author, on behalf of all the authors, jointly and severally, certifies that their institution has approved the protocol for any investigation involving humans or animals and that all experimentation was conducted in conformity with ethical and humane principles of research. This project has been approved by the Western Sydney Local Health District Human Ethics Committee on 27 September 2021 (Identification No. 2021\/ETH10976).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}}]}}